Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

1:12:52
 
Share
 

Manage episode 503643141 series 2970140
Content provided by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Remixed- Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

---In this episode we provide and educational episode remix made with software assistance ( for educational purposes only) , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--

Please note: The views of this podcast represent those of my guest(s) and I, and do not constitute professional or medical advice or consultation. Please see a medical professional or healthcare professional for advice, suggestions and consultations. We disclaim any loss in any way.

Music citation: Open source

  continue reading

318 episodes

Artwork
iconShare
 
Manage episode 503643141 series 2970140
Content provided by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC, Mr. David Joshua Ferguson, MS, PharmD Candidate, and RSci MRSB MRSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Remixed- Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

---In this episode we provide and educational episode remix made with software assistance ( for educational purposes only) , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--

Please note: The views of this podcast represent those of my guest(s) and I, and do not constitute professional or medical advice or consultation. Please see a medical professional or healthcare professional for advice, suggestions and consultations. We disclaim any loss in any way.

Music citation: Open source

  continue reading

318 episodes

Tüm bölümler

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play